Serum Lipids in Cholelithiasis: Effect of Chenodeoxycholic Acid Therapy

Bell, G. D.; Lewis, B.; Petrie, A.; Dowling, R. Hermon
September 1973
British Medical Journal;9/8/1973, Vol. 3 Issue 5879, p520
Academic Journal
No abstract available.


Related Articles

  • Chenodiol for gallstones: dissolution or disillusion? Isselbacher, Kurt J.; Isselbacher, K J // Annals of Internal Medicine;Sep81, Vol. 95 Issue 3, p377 

    Editorial. Discusses research on the effectiveness of chenodeoxycholic acid in dissolving cholesterol gallstones. Methodology; Results; Risks associated with the use of chenodeoxycholic acid.

  • Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid. Bateson, M.C.; Ross, P.E.; Murison, J.; Bouchier, Ian A.D. // British Medical Journal;5/6/1978, Vol. 1 Issue 6121, p1171 

    Giving clofibrate 2 g daily to seven patients significantly increased the biliary cholesterol concentration while the proportion of bile acids fell. Five patients on established clofibrate treatment were given 750 mg of chenodeoxycholic acid (CDCA) daily for one month. Biliary lipid analysis...

  • Choosing patients for chenodeoxcholic acid treatment.  // British Medical Journal;4/30/1977, Vol. 1 Issue 6069, p1119 

    Examines the effectiveness of oral chenodeoxycholic acid on gallstones dissolution. Need to identify the response of patients to chenodeoxycholic acid; Factors considered for identifying patients for chenodeoxycholic acid treatment; Effect of the treatment on patients with biliary tract...

  • Treatment and follow-up of children with cerebrotendinous xanthomatosis. van Heijst, A. F. J.; Verrips, A.; Wevers, R. A.; Cruysberg, J. R. M.; Renier, W. O.; Tolboom, J. J. M.; van Heijst, A F; Cruysberg, J R; Tolboom, J J // European Journal of Pediatrics;1998, Vol. 157 Issue 4, p313 

    Unlabelled: The clinical spectrum and the effects of treatment over a period of 5 years in five children with cerebrotendinous xanthomatosis (CTX) are described. In all children biochemical, neuroradiological, and neurophysiological studies were done. CTX was diagnosed and effects...

  • Chenodeoxycholic Acid Therapy of Gallstones, Progress Report 1975. Pertsemlidis, Demetrius; Greenstein, Adrian J.; Jacobs, Walter H. // American Journal of Gastroenterology;Apr1977, Vol. 67 Issue 4, p385 

    Reviews the book "Chenodeoxycholic Acid Therapy of Gallstones: Progress Report 1975," edited by A. F. Hoffman and G. Paumgartner.

  • Chenodeoxycholic Acid Therapy of Gallstones. Greenstein, Adrian J.; Jacobs, Walter H. // American Journal of Gastroenterology;Apr1976, Vol. 65 Issue 4, p372 

    Reviews the book "Chenodeoxycholic Acid Therapy of Gallstones," edited by Alan F. Hofmann and G. Paumgartner.

  • Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Jonkers, I.J.A.M.; Smelt, A.H.M.; Ledeboer, M.; Hollum, M.E.; Biemond, I.; Kuipres, F.; Stellaard, F.; Boverhof, R.; Meinders, A.E.; Lamers, C.H.B.W.; Masclee, A.A.M. // Gut;Jan2003, Vol. 52 Issue 1, p109 

    Background and aim: The aim of this study was to unravel the mechanisms responsible for the increased risk of gall stone disease in hypertriglyceridaemia (HTG) and to compare the effects of triglyceride lowering therapy by bezafibrate and fish oil on determinants of cholelithiasis (biliary lipid...

  • The National Cooperative Gallstone Study report: a surgeon's perspective. McSherry, Charles K.; McSherry, C K // Annals of Internal Medicine;Sep81, Vol. 95 Issue 3, p379 

    Editorial. Compares the results of several reports on the effectiveness of chenodeoxycholic acid in the dissolution of cholesterol gallstones with the National Cooperative Gallstone Study. Mortality rate of patients with nonmalignant disease of the biliary tract; Examination of the efficacy of...

  • Use of ursodeoxycholic acid in patients with hypertransaminasemia. Puoti, Claudio; Elmo, Maria Giuseppa // Italian Journal of Medicine;2014, Vol. 8 Issue 3, p141 

    Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid deriving from 7β epimerization of primary bile compound chenodeoxycholic acid. It may have antioxidant, immunomodulatory, antifibrotic and cytoprotective effects, therefore it has been extensively used in the treatment of cholestatic...

  • Chenodeoxycholic acid.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p68 

    A case study is presented of an infant girl diagnosed with cerebrotendinous xanthomatosis who later developed toxic hepatitis during therapy with chenodeoxycholic acid supplementation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics